NeuroPace: Volatile, Uncertain, But Promising
Source: SeekingAlpha
2025-06-29 16:00:00 ET
In August of last year, I called NeuroPace ( NPCE ) a stock only suited for those with strong nerves. The company, which aims to improve lives of epilepsy patients with its RNS technology, helps patients in the drug-resistant epilepsy part of the market. ...
Read the full article on Seeking Alpha
For further details see:
NeuroPace: Volatile, Uncertain, But Promising
Neuropace Inc.
NASDAQ: NPCE
NPCE Trading
-1.19% G/L:
$14.06 Last:
15,272 Volume:
$14.17 Open:
NPCE Latest News
March 03, 2026 04:05:00 pm
NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
NPCE Stock Data
$508,942,176
26,479,649
0.24%
22
N/A
Medical Equipment & Supplies
Healthcare
US
Mountain View
